4
Changes in Ownership
Alzamend Neuro, Inc. Filed Acc 0001214659-25-014752
Director sold 139,412 shares at an average $2.47 ($344,222)
- Director acquired 200,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
AULT MILTON C III · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-03 | Conversion : show line 1 in the form | +100,000 | $2.32 | $232,000 | 108,260 | I |
| 2025-10-06 | Sale : show line 2 in the form | −82,033 | $2.45 | $201,268 | 26,227 | I |
| 2025-10-07 | Conversion : show line 3 in the form | +100,000 | $2.32 | $232,000 | 126,227 | I |
| 2025-10-07 | Sale : show line 4 in the form | −57,379 | $2.49 | $142,954 | 68,848 | I |
| Open-market sales · 139,412 sh · avg $2.47 · $344,222 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-03 | Conversion : show line 5 in the form Series B Convertible Preferred Stock | −232 | $1,000.00 | $232,000 | 375.24 | I |
| 2025-10-07 | Conversion : show line 6 in the form Series B Convertible Preferred Stock | −232 | $1,000.00 | $232,000 | 143.24 | I |
Loading xslF345X05/marketforms-71017.xml…